1887

Chapter 13.18 : Screening for Vancomycin-Resistant Enterococci

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in
Zoomout

Screening for Vancomycin-Resistant Enterococci, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555817435/9781555815271_Chap13_18-1.gif /docserver/preview/fulltext/10.1128/9781555817435/9781555815271_Chap13_18-2.gif

Abstract:

Vancomycin-resistant enterococci (VRE) (also referred to as glycopeptide-resistant enterococci) have emerged as significant nosocomial pathogens. Immunosuppression and indwelling devices are risk factors for invasive infections ( ). Transmission on hospital wards is the major source of spread of these antibiotic-resistant organisms. Infection rates can be reduced by screening high-risk groups ( ). Patients colonized with VRE are isolated to prevent transmission. The laboratory, in conjunction with the Infection Control Program, should decide which groups of patients to screen and the frequency of screening depending on the local epidemiology, unless regulations state otherwise ( ).

Citation: Garcia L. 2010. Screening for Vancomycin-Resistant Enterococci, p 535-537. In Clinical Microbiology Procedures Handbook, 3rd Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817435.ch13.18
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555817435.chap13.18
1. Brown, D. F.,, and E. Walpole. 2003. Evaluation of selective and enrichment media for isolation of glycopeptide-resistant enterococci from faecal specimens. J. Antimicrob. Chemother. 51:289296.
2. Grabsch, E. A.,, S. Ghaly-Derias,, W. Gao,, and B. P. Howden. 2008. Comparative study of selective chromogenic (chromID VRE) and bile esculin agars for isolation and identification of vanB-containing vancomycin-resistant enterococci from feces and rectal swabs. J. Clin. Microbiol. 46:40344036.
3. Olivier, C. N.,, R. K. Blake,, L. L. Steed,, and C. D. Salgado. 2008. Risk of vancomycin-resistant Enterococcus (VRE) bloodstream infection among patients colonized with VRE. Infect. Control Hosp. Epidemiol. 29:404409.
4. Price, C. S.,, S. Paule,, G. A. Noskin,, and L. R. Peterson. 2003. Active surveillance reduces the incidence of vancomycin-resistant enterococcal bacteremia. Clin. Infect. Dis. 37:921928.
5. Reisner, B. S.,, S. Shaw,, M. E. Huber,, C. E. Woodmansee,, S. Costa,, P. S. Falk, et al. 2000. Comparison of three methods to recover vancomycin-resistant enterococci (VRE) from perianal and environmental samples collected during a hospital outbreak of VRE. Infect. Control Hosp. Epidemiol. 21:775779.
6. Sakka, V.,, S. Tsiodras,, L. Galani,, A. Antoniadou,, M. Souli,, I. Galani, et al. 2008. Riskfactors and predictors of mortality in patients colonised with vancomycin-resistant enterococci. Clin. Microbiol. Infect. 14:1421.
7. Stamper, P. D.,, M. Cai,, C. Lema,, K. Eskey,, and K. C. Carroll. 2007. Comparison of the BD GeneOhm VanR assay to culture for identification of vancomycin-resistant enterococci in rectal and stool specimens. J. Clin. Microbiol. 45:33603365.
8. Weber, S. G.,, S. S. Huang,, S. Oriola,, W. C. Huskins,, G. A. Noskin,, K. Harriman, et al. 2007. Legislative mandates for use of active surveillance cultures to screen for methicillinresistant Staphylococcus aureus and vancomycin-resistant enterococci: position statement from the Joint SHEA and APIC Task Force. Infect. Control Hosp. Epidemiol. 28:249260.

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error